home / stock / stml / stml news

STML News and Press, Stemline Therapeutics Inc. From 01/30/19

Stock Information
Company Name: Stemline Therapeutics Inc.
Stock Symbol: STML
Market: NASDAQ
Website: stemline.com
Menu
STML STML Quote STML Short STML News STML Articles STML Message Board
Get STML Alerts

News, Short Squeeze, Breakout and More Instantly...
STML - Stemline Therapeutics Announces Validation of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)

NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today announced that the European Medicines Agency (EMA) has completed its va...
STML - Consolidated Research: 2019 Summary Expectations for Marriott International, Calavo Growers, Kinsale Capital Group, Fluidigm, Goldman Sachs BDC, and Stemline Therapeutics - Fundamental Analysis, Key Performance Indications

NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Marriott International (NASDAQ:MAR), Calavo Growers, Inc. (NASDAQ:CVGW...

STML - Stemline Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference

NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that Ivan Bergstein, M.D., Stemline’s CEO, will present at the H.C. Wainwright 20 th Annual Glo...

STML - How Stemline's Latest Catalyst Shifts The Investment Thesis

2018 has been no stranger to exciting developments in biotech, what with the first approvals for RNAi technology, emerging gene therapies, and treatment options for rare forms of cancer. In particular, for me, it's been a banner year for several companies going it on their own in the develop...
STML - Your Daily Pharma Scoop: Redhill Receives NoA, Regeneron Gets CRL, Stemline NDA Under Review

Stocks in News: RDHL, REGN RedHill Bio nabs U.S. patent covering RHB-104 and RHB-204 Discussion : RedHill Biopharma ( RDHL ) received a Notice of Allowance for its new formulation covering RHB-104 in Crohn's disease and RHB-204 in pulmonary nontuberculous mycobacteria infections. The ...

STML - 3 Things In Biotech, August 14: Is Stemline Finally A Go In Cancer?

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. AstraZeneca goes to the home stretch for their updated label in COPD Company: AstraZene...

STML - Stemline Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference

NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that Ivan Bergstein, M.D., Stemline’s CEO, will present at the 2018 Wedbush PacGrow Healthcare Co...
Previous 10 Next 10